55478-23-4

Usage

Uses

Used in Pharmaceutical Research:
Z-DAB(Z)-OH is utilized as a research tool to investigate the role of DPP-IV in diabetes and other metabolic disorders. Its ability to inhibit DPP-IV activity provides insights into the development of treatments for these conditions.
Used in Cancer Treatment Research:
In the field of oncology, Z-DAB(Z)-OH is explored for its potential as a therapeutic agent against cancer. Its specific mechanisms and efficacy in combating cancer cells are under investigation.
Used in Antiviral and Antimicrobial Research:
Z-DAB(Z)-OH is also being studied for its antiviral and antimicrobial properties, indicating its potential use in the development of treatments for viral and bacterial infections.
Used in Laboratory Settings:
Due to its reactivity and stability, Z-DAB(Z)-OH is an important compound in various laboratory experiments, where its chemical behavior in different environments is a critical factor for successful research outcomes.

Upstream product

• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 
• 1482-98-0 (S)-2,4-diaminobutyric acid dihydrochloride 
• 501-53-1 benzyl chloroformate 
• 1482-98-0 L-2,4-diaminobutyric acid monohydrochloride 

Downstream Products

• 154491-37-9 ((S)-2,4-Bis-benzyloxycarbonylamino-butyrylamino)-acetic acid methyl ester 
• 118507-50-9 (3S)-3-benzyloxycarbonylamino-2-pyrrolidinone 
• 4127-89-3 N-((S)-2,4-bis-benzyloxycarbonylamino-butyryl)-L-leucine 
• 1356085-24-9 6-N-benzyloxycarbonyl-2',3'-O-benzylidene-5'-O-[N-(2,4-di(benzyloxycarbonylamino)-L-butyryl)sulfamoyl]adenosine 
• 4127-89-3 Dibenzyloxycarbonyl-L-α,γ-diamino-butyryl-D-leucin 
• 55478-26-7 N^α,N^γ-Di-Z-L-α,γ-Dab-N^γ-Z-L-α,γ-Dab-NHNH2 
• 55478-28-9 N-((S)-2,4-bis-benzyloxycarbonylamino-butyryl)-glycine hydrazide 
• 55478-22-3 N^α,N^γ-Di-Z-L-α,γ-Dab-N^γ-Z-L-α,γ-Dab-OMe 
• 55478-25-6 N-((S)-2,4-bis-benzyloxycarbonylamino-butyryl)-glycine ethyl ester 
• 4218-64-8 (S)-2,4-bis-benzyloxycarbonylamino-butyric acid amide 
• 4127-88-2 Dibenzyloxycarbonyl-L-α,γ-diamino-butyryl-D-leucin-ethylester 
• 102317-34-0 (S)-3-benzyloxycarbonylamino-2-oxo-pyrrolidine-1-carboxylic acid benzyl ester 
• 4127-88-2 N-((S)-2,4-bis-benzyloxycarbonylamino-butyryl)-L-leucine ethyl ester 

Relevant academic research and scientific papers

NOVEL COMPOUNDS AND METHODS OF USE TREATING FRUCTOSE-RELATED DISORDERS OR DISEASES

Disclosed herein are novel compounds that inhibit fructokinase (KHK or ketohexokinase) and the downstream metabolic effects mediated by fructose metabolism. Fructokinase inhibitors specifically block the metabolism of both dietary and endogenous fructose

The synthesis of unusual tetrahydropyrimidine amino acids

The synthesis of derivatives of 2-(1-an-aminoalkyl)-4-carboxy-3,4,5,6-tetrahydropyrimidines, unusual amino acids isolated from bacterial siderophores, is described, from condensation of N-protected amino acids imidates or thiomidates with 2,4-diaminobutyrylglycine methyl ester.